HNRC: Publications »

Register for additional publication utilities	Advanced search options
HNRC Publications

Browse alphabetically by last name of the primary author. Select Letter:

Ances BM, Letendre SL, Alexander T, Ellis RJ. (2008). Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders. International Review of Psychiatry (Abingdon, England), 20(1), 89-93.

Atkinson JH, Heaton RK, Patterson TL, Wolfson T, Deutsch R, Brown SJ, Summers J, Sciolla A, Gutierrez R, Ellis RJ , Abramson I, Hesselink JR, McCutchan JA , Grant I. (2008). Two-year prospective study of Major Depressive Disorder in HIV-infected men. Journal of Affective Disorders, 108(3), 225-234.

Bozzette SA, Ake CF, Tam HK, Phippard A, Cohen D, Scharfstein DO, Louis TA. (2008). Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999), 47(3), 338-41.

Brew BJ, Letendre SL. (2008). Biomarkers of HIV related central nervous system disease. International Review of Psychiatry (Abingdon, England), 20(1), 73-88.

Cachay ER, Frost SD, Poon AF, Looney D, Rostami SM, Pacold ME, Richman DD, Little SJ, Smith DM. (2008). Herpes Simplex Virus Type 2 acquisition during recent HIV infection does not influence plasma HIV levels. Journal of Acquired Immune Deficiency Syndromes (1999), 47(5), 592-596.

Chittiprol S, Kumar AM, Satishchandra P, Taranath SK, Bhimasena Rao RS, Subbakrishna DK, Philip M, Satish KS, Ravi KH, Kumar M. (2008). Progressive dysregulation of autonomic and HPA axis functions in HIV-1 Clade C infection in South India. Psychoneuroendocrinology, 33(1), 30-40.

Everall IP, Grant I. (2008). Special issue dedicated to the topic of HIV. Introduction. International Review of Psychiatry, 20, 1.

Gonzalez R, Cherner M. (2008). Co-factors in HIV neurobehavioural disturbances: substance abuse, Hepatitis C and aging. International Review of Psychiatry (Abingdon, England), 20(1), 49-60.

Grant I., (2008). Neurocognitive disturbances in HIV. International Review of Psychiatry, 20, 33-47.

Hult B, Chana G, Masliah E, Everall I. (2008). Neurobiology of HIV. International Review of Psychiatry (Abingdon, England), 20(1), 3-13.

Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ; for the CHARTER Group. (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Archives of Neurology, 65, 65-70.

Letendre S, McCutchan JA, Ellis RJ. (2008). Neurologic complications of HIV disease and their treatment. Topics in HIV Medicine : a Publication of The International AIDS Society, USA, 16(1), 15-22.

Mocchetti I, Bachis A, Masliah E. (2008). Chemokine receptors and neurotrophic factors: potential therapy against AIDS dementia. J Neurosci Res, 86(2), 243-55.

Morgan EE, Woods SP, Scott JC, Childers M, Marquie Beck J, Ellis RJ, Grant I, Heaton RK, and the HNRC Group. (2008). Predictive validity of demographically-adjusted normative standards for the HIV Dementia Scale. Journal of Clinical and Experimental Neuropsychology, 30 (1), 83-90.

Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, Fishman S. (2008). A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. The Journal of Pain : Official Journal of The American Pain Society, , .

Woods SP, Scott JC, Fields JA, Poquette A, Alexander I. (2008). Executive dysfunction and neuropsychiatric symptoms predict lower health status in essential tremor. Cognitive And Behavioral Neurology : Official Journal of The Society for Behavioral And Cognitive Neurology, 21(1), 28-33.

Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I, and the HNRC Group. (2008). HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology, 22, 110-117.

Woods SP, Moran LM, Carey CL, Dawson MS, Iudicello JE, Gibson S, Grant I, Atkinson JH, and the HNRC Group. (2008). Prospective memory in HIV infection: Is "remembering to remember" a unique predictor of self-reported medication management?. Archives of Clinical Neuropsychology, 23, 257-270.

Alirezaei M, Watry DD, Flynn CF, Kiosses WB, Masliah E, Williams BRG, Kaul M, Lipton SA, Fox HS. (2007). Human Immunodeficiency Virus-1/surface Glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons. The Journal of Neuroscience : The Official Journal of The Society for Neuroscience, 27(41), 11047-55.

Ances BM, Ellis RJ. (2007). Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol, 27(1), 86-92.

Au A, Cheng C, Chan I, Leung P, Li P, Heaton RK. (2007). Subjective memory complaints, mood, and memory deficits among HIV/AIDS patients in Hong Kong. Journal of Clinical And Experimental Neuropsychology : Official Journal of The International Neuropsychological Society, , 1-11.

Berman JW, Carson MJ, Chang L, Cox BM, Fox HS, Gonzalez RG, Hanson GR, Hauser KF, Ho W, Hong J, Major EO, Maragos WF, Masliah E, McArthur JC, Miller DB, Nath A, O`Callaghan JP, Persidsky Y, Power C, Rogers TJ, Royal W. (2007). NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 1(4), 351-99.

Cherner M, Suarez P, Lazzaretto D, Fortuny LA, Mindt MR, Dawes S, Marcotte T, Grant I, Heaton R. the HNRC group (2007). Demographically corrected norms for the Brief Visualspatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.-Mexico border region. Arch Clin Neuropsychol, 22(3), 343-53.

Cherner M, SuÃrez P, Posada C, Fortuny LA, Marcotte T, Grant I, Heaton RK, and the HNRC Group. (2007). Equivalency of Spanish language versions of the Trail Making Test Part B including or excluding "Ch". Clin Neuropsychol, , 1-4.

Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I and the HNRC Group. HNRC Group (2007). Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol, 13 (1)(1), 23-28.

Cysique LA, Deutsch R, Atkinson JH, Young C, Marcotte TD, Dawson L, Grant I, Heaton RK. HNRC GrouP (2007). Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc, 13(1), 1-11.

Cysique LA, Jin H, Franklin Jr DR, Morgan EE, Shi C, Yu X, Wu Z, Taylor MJ, Marcotte TD, Letendre S, Ake C, Grant I, Heaton RK, and the HNRC Group. (2007). Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. Journal of the International Neuropsychological Society, 13, 781-790.

Ellis R, Langford D, Masliah E. (2007). HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci, 8(1), 33-44.

Ellis RJ, Joseph J, de Almeida SM. (2007). NeuroAIDS in Brazil. J Neurovirol, 13(2), 89-96.

Ellis RJ., (2007). Evidence-based treatment for HIV-associated dementia and cognitive impairment: why so little?. PLoS Clin Trials, 2(3), e15.

Ellis RJ., (2007). Clinical trials in HIV CNS disease and treatment management. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 2(1), 20-5.

Evans SR, Yeh T, Sacktor N, Clifford DB, Simpson D, Miller EN, Ellis RJ, Valcour V, Marra CM, Millar L, Schifitto G. (2007). Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials, 8(6), 437-46.

Flynn PM, Rodman J, Lindsey JC, Robbins B, Capparelli E, Knapp KM, Rodriguez JF, McNamara J, Serchuck L, Heckman B, Martinez J. (2007). Intracellular pharmacokinetics of once versus twice daily Zidovudine and Lamivudine in adolescents. Antimicrob Agents Chemother, 51(10), 3516-22.

Gongvatana A, Woods SP, Taylor MJ, Vigil O, Grant I. HNRC Group (2007). Semantic clustering inefficiency in HIV-associated dementia. J Neuropsychiatry Clin Neurosci, 19(1), 36-42.

Gonzalez R, Miller SW, Carey CL, Woods SP, Rippeth JD, Schweinsburg BC, Norman MA, Martin EM, Heaton RK. (2007). Association between dyads and correct responses on the Paced Auditory Serial Addition Task (PASAT). Assessment, 13(4), 381-4.

Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M. (2007). Neuropsychological deficits in Human Immunodeficiency Virus Type 1 Clade C-seropositive adults from south India. J Neurovirol, 13(3), 195-202.

Huang JS, Letendre S, Marquie-Beck J, Cherner M, McCutchan JA, Grant I, Ellis R. (2007). Low CSF Leptin levels are associated with worse learning and memory performance in HIV-infected men. Journal of Neuroimmune Pharmacology, 2 (4), 352-358.

Iudicello JE, Woods SP, Parsons TD, Moran LM, Carey CL, Grant I. (2007). Verbal fluency in HIV infection: a meta-analytic review. J Int Neuropsychol Soc, 13(1), 183-9.

Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E, and the HNRC Group. (2007). Pathogenesis of Hepatitis C Virus co-infection in the brains of patients infected with HIV. Journal of Infectious Diseases, 196(3), 361-370.

Letendre SL, van den Brande G, Hermes A, Woods SP, Durelle K, Beck JM, McCutchan JA, Okamoto C, Ellis RJ, and the HNRC Group. (2007). Lopinavir with Ritonavir reduces the HIV RNA level in cerebrospinal fluid. Clinical Infectious Diseases : An Official Publication of The Infectious Diseases Society of America, 45(11), .

Letendre SL, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson D, Alexander TJ, Durelle J, Heaton R, Grant I; CHARTER Group. (2007). The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. Journal of Neuroimmune Pharmacology, 2 (1), 120-127.

May S, Letendre S, Haubrich R, McCutchan J A, Heaton R, Capparelli E, Ellis R. (2007). Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in NeuroAIDS. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 2(1), 97-104.

Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, Lenkinski RE, Cohen RA, Navia BA. (2007). Proton MRS and neuropsychological correlates in AIDS Dementia Complex: evidence of subcortical specificity. The Journal of Neuropsychiatry And Clinical Neurosciences, 19(3), 283-92.

Podzamczer D, King MS, Klein CE, Flexner C, Katlama C, Havlir DV, Letendre SL, Eron JJ, Brun SC, Bernstein B. (2007). High-dose Lopinavir/Ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response. HIV Clinical Trials, 8(4), 193-204.

Sadek JR, Vigil O, Grant I, Heaton RK. The HNRC Group (2007). The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol, 29(3), 266-76.

Salaria S, Badkoobehi H, Rockenstein E, Crews L, Chana G, Masliah E, Everall IP, and the HNRC Group. (2007). Toll-like receptor pathway gene expression is associated with Human Immunodeficiency Virus-associated neurodegeneration. Journal of Neurovirology, 13, 496-503.

Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA. (2007). Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS (London, England), 21(14), 1877-86.

Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I. (2007). Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychology Review, 17, 275-297.

Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I, and the HNRC Group. (2007). Effects of Human Immunodeficiency Virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol, 13(2), 150-9.

Vigil O, Woods SP, Moran LM, Letendre SL, Young-Casey C, Grant I, Atkinson JH, and the HNRC Group. (2007). Is Hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence. The American Journal on Addictions, 16, 418-423.

Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD. (2007). HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people. AIDS (London, England), 21(11), 1415-22.

Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I. (2007). Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology, 107(5), 785-96.

Woods SP, Carey CL, Moran LM, Dawson MS, Letendre SL, Grant I. HIV Neurobehavioral Research Center (HNRC) Group (2007). Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Arch Clin Neuropsychol, 22(2), 187-95.

Woods SP, Morgan EE, Marquie-Beck J, Carey CL, Grant I, Letendre SL. The HIV Neurobehavioral Research Center (HNRC) Group (2007). Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol, 19(4), 217-21.

Ances BM, Letendre S, Buzzell M, Marquie-Beck J, Lazaretto D, Marcotte TD, Grant I, Ellis RJ. HNRC Group (2006). Valproic Acid does not affect markers of Human Immunodeficiency Virus disease progression. J Neurovirol, 12(5), 403-6.

Carey CL, Woods SP, Morgan EE, Rippeth JD, Dawson M, Grant I, and the HNRC group. (2006). Prospective memory complaints in HIV-1 infection. J Int Neuropsychol Soc, 12(Suppl 1), 151. (Abst.)

Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I, and the HNRC Group. HIV Neurobehavioral Research Center (HNRC) Group (2006). Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. J Clin Exp Neuropsychol, 10(2)(4), 185-190.

Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I, and the HNRC Group. HIV Neurobehavioral Research Center (HNRC) Group (2006). Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol, 28(4), 536-548.

Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E. HNRC Group (2006). Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology, 67(8), 1486-9.

Cherner M, Suárez P, Dawes SE, Rivera Mindt M, Marcotte TD, Heaton RK, Grant I. (2006). Relationship between cognitive deficits and performance on tests of everyday functioning in HIV+ Spanish speakers: preliminary results. J Int Neuropsychol Soc, 12(Suppl 1), 57. (Abst.)

Dawes S, Suárez P, Casey C, Cherner M, Grant I, Heaton R, and the HNRC group. (2006). Examination of cognitive profiles in a HIV positive sample. J Int Neuropsychol Soc, 12(Suppl 1), 33-34. (Abst.)

Dawes S, Cysique L, Lazzaretto D, Moran LM, Woods SP, Heaton RK, Grant I, and the HNRC Group. (2006). Trail Making Test and the relative efficacy of discrepancy analysis in an HIV positive sample. J Int Neuropsychol Soc, , . (Abst.)

Dawes S, Suárez P, Cherner M, Grant I, Heaton RK, and the HNRC group. (2006). Preliminary normative data for the Patient`s Assessment of Own Functioning Inventory. J Int Neuropsychol Soc, 12(Suppl 1), 33-34. (Abst.)

Dawes S, Suárez, P, Casey C, Cherner M, Grant I, Heaton R, and the HNRC group. (2006). Utility of a clustering method for analyzing neuropsychological test data in an HIV positive sample. J Int Neuropsychol Soc, , . (Abst.)

de Almeida MS, Letendre S, Zimmerman J, Kolakowski S, Lazzaretto D, McCutchan JA, Ellis R. (2006). Relationship of CSF Leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy. J Neuroimmunol, 179(1-2), 180-5.

de Almeida MS, Letendre S, Zimmerman J, Lazzaretto D, McCutchan A, Ellis R. (2006). Dynamics of Monocyte Chemoattractant Protein Type One (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. J Neuroimmunol, 169(1-2), 144-52.

de Almeida SM, Letendre S, Ellis R. (2006). Human Immunodeficiency Virus and the central nervous system. Braz J Infect Dis, 10(1), 41-50.

Everall IP, Hansen LA, Masliah E. (2006). The shifting patterns of HIV encephalitis neuropathology. Neurotox Res, 8(1-2), 51-61.

Everall IP, Salaria S, Atkinson JH, Young C, Corbeil J, Grant I, Masliah E. HNRC (HIV Neurobehavioral Research Center) (2006). Diminished Somatostatin gene expression in individuals with HIV and Major Depressive Disorder. Neurology, 67(10), 1867-9.

Fennema-Notestine C, Ozyurt IB, Clark CP, Morris S, Bischoff-Grethe A, Bondi MW, Jernigan TL, Fischl B, Segonne F, Shattuck DW, Leahy RM, Rex DE, Toga AW, Zou KH, Brown GG. (2006). Quantitative evaluation of automated skull-stripping methods applied to contemporary and legacy images: effects of diagnosis, bias correction, and slice location. Hum Brain Mapp, 27(2), 99-113.

Gongvatana A, Woods SP, Taylor MJ, Grant I. (2006). Semantic clustering inefficiency in HIV-associated dementia. J Int Neuropsychol Soc, 12(Suppl 1), 149-150. (Abst.)

Gonzalez R, Grant I, Miller SW, Taylor MJ, Schweinsburg BC, Carey CL, Woods SP, Norman MA, Rippeth JD, Martin EM, Heaton RK. (2006). Demographically adjusted normative standards for new indices of performance on the Paced Auditory Serial Addition Task (PASAT). Clin Neuropsychol, 20(3), 396-413.

Jin H, Atkinson HJ, Yu X, Heaton RK, Shi C, Marcotte TP, Young C, Sadek J, Wu Z, Grant I. HNRC China collaboration group (2006). Depression and suicidality in HIV/AIDS in China. J Affect Disord, 94(1-3), 269-75.

Langford D, Marquie-Beck J, de Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ. (2006). Relationship of antiretroviral treatment to postmortem brain tissue viral load in Human Immunodeficiency Virus-infected patients. J Neurovirol, 12(2), 100-7.

Letendre S, Ellis RJ. (2006). Neurologic complications of HIV disease and their treatments. Top HIV Med, 14(1), 21-6.

Letendre S.L, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I. HNRC Group (2006). Lithium improves HIV-associated neurocognitive impairment. AIDS, 20(14), 1885-8.

Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I, and the HNRC Group. HNRC Group (2006). The effects of Hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS, 19 Suppl 3(Suppl 3), S72-8.

Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S. HNRC Group (2006). Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol, 28(1), 13-28.

Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I. HNRC Group (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS, 20(6), 879-87.

Moore DJ, Woods SP, Lazzaretto DL, Depp CA, Atkinson JH, Heaton RK, Grant I, and the HNRC group. (2006). Cognitive impairment among individuals with Bipolar Disorder and HIV infection. J Int Neuropsychol Soc, 12(Suppl 1), 150. (Abst.)

Morgan EE, Woods S, Scott J, Childers M, Ellis RJ, Grant I, Heaton RK, and the HNRC group. (2006). Development and predictive validity of demographically-adjusted normative data for the HIV Dementia Scale. J Int Neuropsychol Soc, 12(Suppl 1), 149. (Abst.)

Morgello S, Holzer CE, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ. National NeuroAIDS Tissue Consortium. (2006). Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. Int J Methods Psychiatr Res, 15(3), 131-8.

Patterson K, Young C, Woods SP, Vigil O, Grant I, Atkinson JH, and the HNRC Group. The HIV Neurobehavioral Research Center (HNRC) Group. (2006). Screening for major depression in persons with HIV infection: the concurrent predictive validity of the Profile of Mood States Depression-Dejection Scale. Int J Methods Psychiatr Res, 15(2), 75-82.

Rossi S, Yaksh T, Bentley H, van den Brande G, Grant I, Ellis R. (2006). Characterization of interference with 6 commercial Delta9-tetrahydrocannabinol immunoassays by Efavirenz (glucuronide) in urine. Clin Chem, 52(5), 896-7.

Schweinsburg BC, Woods SP, Schweinsburg AD, Paulus MP, Grant I, and the HNRC group. (2006). Neural substrates of response inhibition in HIV- infection. J Int Neuropsychol Soc, 12(Suppl 1), 58. (Abst.)

Scott JC, Woods SP, Patterson KA, Morgan EE, Heaton RK, Grant I, Marcotte TD. HIV Neurobehavioral Research Center Group (2006). Recency effects in HIV-associated dementia are characterized by deficient encoding. Neuropsychologia, 44(8), 1336-43.

Scott JC, Woods S, Patterson KA, Morgan EE, Heaton RK, Grant I, Marcotte TD, and the HNRC Group. (2006). Recency effects in HIV-associated dementia are characterized by deficient encoding. J Int Neuropsychol Soc, 12(Suppl 1), 148-149. (Abst.)

Suárez PA, Cherner M, Dawes S, Grant I, Heaton RK. (2006). The relationship between subjective cognitive complaints, depressive symptoms and neuropsychological functioning among HIV- seropositive Spanish vs English speakers. J Int Neuropsychol Soc, 12(Suppl 1), 79. (Abst.)

Woods S, Dawson MS, Carey CL, Morgan EE, Scott J, Grant I, and the HNRC Group. (2006). Increased cognitive load exacerbates HIV-1 associated time-based prospective memory impairment. J Int Neuropsychol Soc, 12(Suppl 1), 148. (Abst.)

Woods S, Schweinsburg BC, Schweinsburg AD, Grant I, and the HNRC group. (2006). Neural substrates of mental rotation in HIV-1 infection. J Int Neuropsychol Soc, 12(Suppl 1), 150. (Abst.)

Woods SP, Twamley EW, Dawson MS, Narvaez JM, Jeste DV. (2006). Deficits in cue detection and intention retrieval underlie prospective memory impairment in Schizophrenia. Schizophr Res, 90(1-3), 344-50.

Woods SP, Morgan EE, Dawson M, Scott CJ, Grant I. HIV Neurobehavioral Research Center (HNRC) Group (2006). Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1. J Clin Exp Neuropsychol, 28(6), 1030-42.

Woods SP, Scott JC, Dawson MS, Morgan EE, Carey CL, Heaton RK, Grant I. HIV Neurobehavioral Research Center (HNRC) Group (2006). Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Arch Clin Neuropsychol, 20(8), 1061-71.

Woods SP, Childers M, Ellis RJ, Guaman S, Grant I, Heaton RK. HIV Neurobehavioral Research Center (HNRC) Group (2006). A battery approach for measuring neuropsychological change. Arch Clin Neuropsychol, 21(1), 83-9.

Achim CL, Masliah E, Schindelar J, Avramut M. (2005). Immunophilin expression in the HIV-infected brain. J Neuroimmunol, 157(1-2), 126-32.

Ancoli-Israel S, McKibbin C, Dimsdale JE, Mills PJ, Archuleta C, Patterson T, Grant I. (2005). Effects of caregiving on sleep appear to be particularly salient among older caregivers. Sleep, 28, A109. (Abst.)

Aschbacher K, Patterson TL, von Kanel R, Dimsdale JE, Mills PJ, Adler KA, Ancoli-Israel S, Grant I. (2005). Coping processes and hemostatic reactivity to acute stress in dementia caregivers. Psychosom Med, 67(6), 964-71.

Atkinson JH, Person C, Young C, Deitch D, Treisman G. (2005). The neurology of AIDS: psychiatric disorders. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 553-566). London: Oxford University Press.

Capparelli EV, Holland D, Okamoto C, Gragg B, Durelle J, Marquie-Beck J, van den Brande G, Ellis R, Letendre S. HNRC Group (2005). Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV. AIDS, 19(9), 949-52.

Capparelli EV, Letendre SL, Ellis RJ, Patel P, Holland D, McCutchan JA. (2005). Population pharmacokinetics of Abacavir in plasma and cerebrospinal fluid. Antimicrob Agents Chemother, 49(6), 2504-6.

Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK. HNRC Group (2005). Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol, 18(2), 234-48.

Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I. (2005). Prospective memory in HIV-1 infection. J Int Neuropsychol Soc, 11 (Suppl S1), 119. (Abst.)

Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I. HIV Neurobehavioral Research Center Group (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 1343-7.

Chuan S, Xin Y, Zunyou W, Heaton RK, Jin H, Marcotte TD, Sadek J, Grant I. (2005). Neuropsychological feasibility study among HIV+/AIDS subjects in China. Chinese Mental Health Journal, 19(5), 343-6.

Dimsdale JE, McKibbin C, Ancoli-Israel S, Patterson TL, Mills PJ, von Känel R, Grant I. (2005). Sleep in caregivers of patients with Alzheimer’s disease vs non-caregivers. Psychosom Med, 67 (1), A5-A6. (Abst.)

Ellis RJ, Merdes A, Masliah E, Langford TD. (2005). Clinical-neuropathological correlation in HIV in the era of highly active antiretroviral therapy. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 799-809). London: Oxford University Press.

Everall I, Shahid S, Roberts E, Corbeil J, Sasik R, Fox H, Grant I, Masliah E, and the HNRC Group. (2005). Methamphetamine stimulates interferon inducible genes in HIV infected brain. Journal of Neuroimmunology, 170 (1-2), 158-171.

Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL. (2005). In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington Disease. Neurology, 63(6), 989-95.

Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells S (Eds.) (2005). The Neurology of AIDS, 2nd Edition. , , .

Grant I, Cahn BR. (2005). Cannabis and endocannabinoid modulators: therapeutic promises and challenges. Clin Neurosci Res, 5(2-4), 185-99.

Grant I, Sacktor N, McArthur J. (2005). HIV neurocognitive disorders. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 357-373). London: Oxford University Press.

Grant I., (2005). Foreword by Igor Grant, M.D., Director, Center for Medicinal Cannabis Research (CMCR). Neuropharmacology, 48(8), 1067.

Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL. (2005). Brain deposition of Beta-amyloid is a common pathologic feature in HIV positive patients. AIDS, 19(4), 407-11.

Hung C, Ellis RJ. (2005). Compartmentalization of HIV infection in the central nervous system. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 628-636). London: Oxford University Press.

Iyer LS, von Känel R, Mills PJ, Ma P, Dimsdale JE, Patterson TL, Grant I. (2005). Impaired fibrinolysis in Alzheimer caregivers of advanced dementia spouses as compared to non-caregiving controls. Psychosom Med, 67 (1), A98. (Abst.)

Jacobson MW, Archibald SL, Grant I, Jernigan TL, and the HNRC Group. (2005). Visuospatial attention and methamphetamine dependence: Increased regional fMRI activation and response latency. J Int Neuropsychol Soc, 11 (Suppl S1), 181. (Abst.)

Jernigan T, Archibald S. (2005). Structural brain imaging. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 567-573). London: Oxford University Press.

Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Mindt MR, Marcotte TD, Marcotte TL, Heaton RK, Ellis RJ, Grant I. (2005). Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry, 162(8), 1461-72.

Langford D, Hurford R, Hashimoto M, Digicaylioglu M, Masliah E. (2005). Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. BMC Neurosci, 6(1), 8.

Lefkowitz M, Grant I. (2005). Pain management in HIV infection. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 811-819). London: Oxford University Press.

Lentz MR, Kim JP, Westmoreland SV, Greco JB, Fuller RA, Ratai EM, He J, Sehgal PK, Halpern EF, Lackner AA, Masliah E, GonzÃlez RG. (2005). Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to Creatine in Macaque brain. Radiology, 235(2), 461-8.

Letendre S., (2005). The effects of antiretroviral therapy on viral and nonviral markers in cerebrospinal fluid. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 617-627). London: Oxford University Press.

Marcotte TD, Heaton RK, Ellis RJ, Grant I, and the HNRC Group. (2005). Neuropsychological impairment in HIV infection: how typical is the”typical profile”?. J Int Neuropsychol Soc, 11 (Suppl S1), 21. (Abst.)

Marcotte TD, Heaton RK, Albert S. (2005). Everyday impact of HIV-associated neurocognitive disorders. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 743-752). London: Oxford University Press.

Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS. (2005). Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol, 157(1-2), 163-75.

Mattison A, Cherner M. (2005). Club drugs and HIV transmission. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 763-771). London: Oxford University Press.

McCutchan JA, Letendre SL. (2005). Pharmocology of antiretroviral drugs in CNS: pharmacokinetics, antiretroviral resistance, and pharmacodynamics. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 729-734). London: Oxford University Press.

Moore DJ, Atkinson JH, Akiskal H, Gonzalez R, Wolfson T, Grant I. HNRC Group (2005). Temperament and risky behaviors: a pathway to HIV. J Affect Disord, 85(1-2), 191-200.

Patterson TL, Semple SJ. (2005). Coping, methamphetamine, and HIV. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 753-762). London: Oxford University Press.

Roberts ES, Masliah E, Fox HS. (2005). CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol, 63(12), 1255-64.

Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, Grant I. HNRC Group (2005). Brain mitochondrial injury in Human Immunodeficiency Virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol, 11(4), 356-64.

Scott J, Woods SP, Dason MS, Carey CL, Marcotte TD, Heaton RK, Grant I, and the HNRC Group. (2005). Component process measures within the Hopkins Verbal Learning Test – Revised: construct validity in an HIV-1 sample. J Int Neuropsychol Soc, 11 (Suppl S1), 21. (Abst.)

Semple SJ, Grant I, Patterson TL. (2005). Negative self-perceptions and sexual risk behavior among heterosexual methamphetamine users. Subst Use Misuse, 40(12), 1797-810.

Semple SJ, Patterson TL, Grant I. (2005). Methamphetamine use and depressive symptoms among heterosexual men and women. Journal of Substance Use, 10(1), 31-47.

Semple SJ, Grant I, Patterson TL. (2005). Utilization of drug treatment programs by methamphetamine users: the role of social stigma. Am J Addict, 14(4), 367-80.

Semple SJ, Zians J, Grant I, Patterson TL. (2005). Impulsivity and methamphetamine use. J Subst Abuse Treat, 29(2), 85-93.

Singh KK, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, Grant I, Spector SA. (2005). CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. J Neuroimmunol, 157(1-2), 185-92.

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Ganthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK. (2005). Genetic composition of Human Immunodeficiency Virus Type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol, 79(3), 1772-88.

Suarez PA, Cherner M, Lazzaretto D, Rivera Mindt M, Artiola L, Grant I, Heaton RK, and the HNRC Group. (2005). Demographically corrected norms for the Brief Visuospatial Memory Test - Revised attenuate education related performance differences among HIV+ Spanish speakers. J Int Neuropsychol Soc, 11 (Suppl S1), 146. (Abst.)

von Kanel R, Ancoli-Israel S, Dimsdale J, Mills P, Patterson TL, Grant I. (2005). Polysomnographic measures of poor sleep quality correlate with procoagulant activity in Alzheimer caregivers. Psychosom Med, 67 (1), A113. (Abst.)

von Känel R, Mills PJ, Adler KA, Dimsdale JE, Patterson TL, Ancoli-Israel S, Grant I. (2005). Psychosocial factors predict exaggerated platelet reactivity to acute mental stress in Alzheimer caregivers. Psychosom Med, 67 (1), A89. (Abst.)

von Känel R, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, Grant I. (2005). Alzheimer caregiving distress and age interact in predicting proinflammatory and procoagulant activity. Psychosom Med, 67 (1), A89. (Abst.)

Woods SP, Carey CL, Troster AI, Grant I. The HIV Neurobehavioral Research Center (HNRC) Group (2005). Action (verb) generation in HIV-1 infection. Neuropsychologia, 43(8), 1144-51.

Woods SP, Scott J, Carey CL, Tröster AI, Heaton RK, Grant I, & the HNRC Group. (2005). Evidence for the construct validity of action (verb) fluency. J Int Neuropsychol Soc, 11 (Suppl S1), 5. (Abst.)

Woods SP, Morgan E, Marquie-Beck J, Carey CL, Grant I, Letendre S, and the HNRC Group. (2005). Neuropathogenesis of prospective memory impairment in HIV-1 infection. Clin Neuropsychol, 19, 563-564. (Abst.)

Woods SP, Scott JC, Sires DA, Grant I, Heaton RK, Tröster AI, and the HNRC Group. (2005). Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc, 11, 408-415.

Woods SP, Rippeth JD, Conover E, Gongvatana A, Gonzalez R, Carey CL, Cherner M, Heaton RK, Grant I. HIV Neurobehavioral Research Center Group (2005). Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology, 19(1), 35-43.

Woods SP, Scott JC, Conover E, Marcotte TD, Heaton RK, Grant I. HIV Neurobehavioral Research Center Group (2005). Test-retest reliability of component process variables within the Hopkins Verbal Learning Test-Revised. Assessment, 12(1), 96-100.

Woods SP, Grant I. (2005). Neuropsychology of HIV. In Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells, S. (Eds.) The Neurology of AIDS, 2nd Edition (pp. 607-616). London: Oxford University Press.

Yiannoutsos CT, Ernst T, Chang L, Lee PL, Richards T, Marra CM, Meyerhoff DJ, Jarvik JG, Kolson D, Schifitto G, Ellis RJ, Swindells S, Simpson DM, Miller EN, Gonzalez RG, Navia BA. (2005). Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage, 23(3), 928-35.

Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, Heaton RK, Grant I Mallory M, Miller A, Jernigan TL. (2004). Correlation of in vivo neuroimaging abnormalities with postmortem Human Immunodeficiency Virus encephalitis and dendritic loss. Arch Neurol, 61(3), 369-76.

Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK. HNRC Group (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol, 26(3), 307-19.

Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK, and the HNRC Group. (2004). Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clinical Neuropsychology, 18 (2), 234-248.

Carey CL, Woods SP, Rippeth JD, Conover E, Heaton RK, Grant I, and the HNRC Group. (2004). Diminished verbal fluency is associated with inefficient lexical-semantic switching in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc, 10 (Suppl S1), 46. (Abst.)

Carlson KA, Limoges J, Pohlman GD, Poluektova LY, Langford D, Masliah E, Ikezu T, Gendelman HE. (2004). OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. J Neuroimmunol, 150(1-2), 186-98.

Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, Grant I, Heaton RK. HIV Neurobehavioral Research Center Group (2004). Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS, 18(Suppl i), S27-34.

Cherner M, Letendre S, Taylor MJ, Heaton RK, Grant I, and the HNRC Group. (2004). Hepatitis C infection is independently associated with neurocognitive dysfunction among individuals with HIV co-infection and/or history of methamphetamine dependence. J Int Neuropsychol Soc, 10 (Suppl S1), 197. (Abst.)

Everall I, Grant I. (2004). Proteomic pointers in HIV neurocognitive disorder. Lancet, 363(9415), 1091-2.

Everall IP., (2004). Interaction between HIV and intravenous heroin abuse?. J Neuroimmunol, 147(1-2), 13-5.

Freeman WR, McCutchan JA, Arevalo JF, Wolfson T, Marcotte TD, Heaton RK, Grant I. HNRC Group (2004). The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era. Ocul Immunol Inflamm, 12(1), 25-33.

Fuller RA, Westmoreland SV, Ratai E, Greco JB, Kim JP, Lentz MR, He J, Sehgal PK, Masliah E, Halpern E, Lackner AA, GonzÃlez RG. (2004). A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS. BMC Neurosci, 5(Mar), 10.

Gonzalez R, Heaton RK, Miller W, Taylor MJ, Jernigan T, Archibald SL, Norman MA, Carey CL, Schweinsburg BC, Rippeth JD, Woods SP, Lazzaretto D, and Grant I. (2004). Measuring HIV and methamphetamine related cognitive impairments using modified scoring guidelines for the PASAT. J Int Neuropsychol Soc, 10 (Suppl S1), 47. (Abst.)

Gonzalez R, Rippeth JD, Carey CL, Heaton RK, Moore DJ, Schweinsburg BC, Cherner M, Grant I. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend, 76(2), 181-90.

Greco JB, Westmoreland SV, Ratai EM, Lentz MR, Sakaie K, He J, Sehgal PK, Masliah E, Lackner AA, GonzÃlez RG. (2004). In vivo 1H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS. Magn Reson Med, 51(6), 1108-14.

Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I. HNRC Group (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc, 10(3), 317-31.

Heaton, R.K., Miller, S.W., Taylor, M.J., Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults Scoring Program. , , .

Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, Sadek J, Madenwald T., Becker JT, Conigliaro J, Brown ST, Rimland D, Crystal S, Simberkoff M. Veterans Aging Cohort 5-Site Study Project Team (2004). Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS, 18(Suppl 1), S49-59.

Langford D, Grigorian A, Hurford R, Adame A, Crews L, Masliah E. (2004). The role of mitochondrial alterations in the combined toxic effects of Human Immunodeficiency Virus Tat protein and methamphetamine on calbindin positive-neurons. J Neurovirol, 10(6), 327-37.

Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen L, Masliah E. (2004). Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J Neuropathol Exp Neurol, 63(10), 1038-47.

Letendre S, Marquie-Beck J, Singh KK, de Almeida S, Zimmerman J, Spector SA, Grant I, Ellis R. HNRC Group (2004). The monocyte chemotactic protein-1-2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid. J Neuroimmunol, 157(1-2), 193-6.

Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, Grant I, Ellis RJ. HNRC Group (2004). Enhancing antiretroviral therapy for Human Immunodeficiency Virus cognitive disorders. Ann Neurol, 56(3), 416-23.

Marcotte TD, Scott JC. (2004). The assessment of driving abilities. Advances in Transportation Studies, , 79-90.

Marcotte TD, Scott JS, Lazzaretto D, Roberts E, Bentley H, Rosenthal TJ, and the HNRC Group. (2004). Long-term stability of standard deviation of lateral position in neurocognitively normal and impaired individuals. Advances in Transportation Studies, , 57-65.

Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzalez R, Ellis RJ, Grant I. HIV Neurobehavioral Research Center Group (2004). A multimodal assessment of driving performance in HIV infection. Neurology, 63(8), 1417-22.

Marcotte TD, Roberts E, Heaton RK, Bentley H, Lazzaretto D, Woods SP, Grant I, and the HNRC Group. (2004). Visual attention and driving accidents in HIV infection. J Int Neuropsychol Soc, 10 (Suppl S1), 47. (Abst.)

Mills PJ, Dimsdale JE, Ziegler MG, Archuleta CC, Patterson TL, Grant I. (2004). Cellular adhesion molecule density in Alzheimer caregivers and non-caregiving controls at rest and following acute psychological stress. Psychosom Med, 66 (1), A49. (Abst.)

Rippeth J, Carey CL, Woods SP, Heaton RK, Grant I, and the HNRC Group. (2004). Cognitive, psychiatric, and medical predictors of relapse in HIV+ methamphetamine abusers. J Int Neuropsychol Soc, 10 (Suppl S1), 20. (Abst.)

Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I. HNRC Group (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc, 10(1), 1-14.

Robbins R, Rivera Mindt M, Heaton RK, Marcotte TD, Grant I, and the HNRC Group. (2004). Are there ethnicity differences in the ability of neuropsychological test performance to predict functional impairment in HIV infection?. J Int Neuropsychol Soc, 10 (Suppl S1), 196. (Abst.)

Ross B, Lin A, Harris K, Bhattacharya P, Schweinsburg B. (2004). Clinical experience with 13C MRS in vivo. NMR Biomed, 16(6-7), 358-69.

Sadek JR, Heaton RK, Woods SP, Rippeth JR, Cherner M, Young C, Lazzaretto D, Grant I, and the HNRC Group. (2004). Impact of depression on self-reported impairment in HIV and methamphetamine use. J Int Neuropsychol Soc, 10 (Suppl S1), 197. (Abst.)

Sadek JR, Johnson SA, White DA, Salmon DP, Taylor KI, Delapena JH, Paulsen JS, Heaton RK, Grant I. (2004). Retrograde amnesia in dementia: comparison of HIV-associated dementia, Alzheimer`s disease, and Huntington`s disease. Neuropsychology, 18(4), 692-9.

Schweinsburg BC, Schweinsburg AD, Taylor MJ, Tapert SF, and Grant I. (2004). Recovery of brain fMRI response to a spatial working memory task in abstinent alcoholics. J Int Neuropsychol Soc, 10 (Suppl S1), 65. (Abst.)

Semple SJ, Patterson TL, Grant I. (2004). Psychosocial characteristics and sexual risk behavior of HIV positive men who have anonymous sex partners. Psychology and Health, 19(1), 71-87.

Semple SJ, Patterson TL, Grant I. (2004). Determinants of condom use stage of change among heterosexually-identified methamphetamine users. AIDS Behav, 8(4), 391-400.

Semple SJ, Patterson TL , Grant I. (2004). Psychosocial and behavioral characteristics of injection methamphetamine users. Ann Behav Med, 27 (Suppl), S141. (Abst.)

Semple SJ, Patterson TL, Grant I. (2004). The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav, 29(4), 807-10.

Semple SJ, Patterson TL, Grant I. (2004). A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend, 76(2), 203-12.

Semple SJ, Grant I, Patterson TL. (2004). Female methamphetamine users: social characteristics and sexual risk behavior. Women Health, 40(3), 35-50.

Summers J, Zisook S, Sciolla AD, Patterson T, Atkinson JH. San Diego HIV Neurobehavioral Research Center (HNRC) Group (2004). Gender, AIDS, and bereavement: a comparison of women and men living with HIV. Death Stud, 28(3), 225-41.

Taylor MJ, Letendre SL, Schweinsburg BC, Alhassoon OM, Brown GG, Gongvatana A, Grant I. HNRC (2004). Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. J Int Neuropsychol Soc, 10(1), 110-3.

Twamley EW, Sadek JR, Narvaez JM, Heaton RK, Jeste DV, Bentley H, Rivera Mindt M, Grant I, and the HNRC Group. (2004). Work-related abilities in Schizophrenia and HIV: a demographically-matched comparison. J Int Neuropsychol Soc, 10 (Suppl S1), 151. (Abst.)

Woods SP, Rippeth JD, Conover E, Gongvatana A, Heaton RK, Grant I, and the HNRC Group. (2004). Deficits in executive control of verbal list learning among individuals with methamphetamine dependence. J Int Neuropsychol Soc, 10 (Suppl S1), 199. (Abst.)

Woods SP, Carey CL, Tröster AI, Grant I, and the HNRC Group. (2004). Action (verb) fluency in HIV-1 infection. J Int Neuropsychol Soc, 10 (Suppl S1), 46-47. (Abst.)

Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK. (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol, 26(6), 759-78.

Woods SP, Conover E, Weinborn M, Rippeth JD, Brill RM, Heaton RK, Grant I. HIV Neurobehavioral Research Center ( HNRC) Group (2004). Base rate of Hiscock Digit Memory Test failure in HIV-associated neurocognitive disorders. Clin Neuropsychol, 17(3), 383-9.

Adler KA, Mills PJ, Dimsdale JE, Ziegler MG, Patterson TL, Grant I. (2003). Beta2 adrenergic receptors are desensitized and downregulated in vulnerable caregivers of spouses with Alzheimer’s disease. Psychosom Med, 65 (1), A33. (Abst.)

Ancoli-Israel S, Patterson TL, Archuleta C, Levenstein S, McKibbin CL, Grant I. (2003). Sleep of caregivers of patients with Alzheimer’s disease. Sleep, 26, A159. (Abst.)

Atkinson JH, Cherner M, Heaton RK, Marcotte T, Grant I. (2003). Prevalence and 1 year course of psychiatric disorder in HIV-infected, methamphetamine-dependent individuals. Psychosom Med, 65 (1), A76. (Abst.)

Chardos JF, Smith D, Letendre S. (2003). Demyelinating encephalitis. Clin Infect Dis, 36(10), 1266-7, 1332.

Chismar JD, Mondala T, Fox HS, Roberts E, Langford D, Masliah E, Salomon DR, Head SR. (2003). Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. Biotechniques, 33(3), 516-8.

Diehr MC, Cherner M, Wolfson TJ, Miller SW, Grant I, Heaton RK. HIV Neurobehavioral Research Center Group (2003). The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. J Clin Exp Neuropsychol, 25(4), 571-85.

Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I. HIV Neurobehavioral Research Center Group (2003). Increased Human Immunodeficiency Virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis, 188(12), 1820-6.

Ellis RJ, Childers ME, Zimmerman JD, Frost SD, Deutsch R, McCutchan JA. The HIV Neurobehavioral Research Center Group (2003). Human Immunodeficiency Virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy. J Infect Dis, 187(11), 1818-21.

Gongvatana A, Marcotte T, Taylor MJ, Gonzalez R, Moore DJ, Carey C, Miller W, Grant I, Heaton RK, and the HNRC Group. (2003). Use of ethnicity-corrected norms in assessing African American and white HIV-infected men. J Int Neuropsychol Soc, 9, 161. (Abst.)

Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I. HIV Neurobehavioral Research Center Group (2003). Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc, 9(1), 64-71.

Grant I, Gelman BB, Morgello S, Singer EJ. (2003). National NeuroAIDS Tissue Consortium [NNTC]. J Neurovirol, 9(3), 113. (Abst.)

Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc, 9(5), 679-89.

Jernigan TL, Gamst AC, Fennema-Notestine C, Ostergaard AL. (2003). More "mapping" in brain mapping: statistical comparison of effects. Hum Brain Mapp, 19(2), 90-5.

Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E. HIV Neurobehavioral Research Center Group (2003). Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr, 34(5), 467-74.

Langford D, Masliah E. (2003). The emerging role of infectious pathogens in neurodegenerative diseases. Exp Neurol, 184(2), 553-5.

Langford TD, Letendre SL, Larrea GJ, Masliah E. (2003). Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol, 13(2), 195-210.

Marcotte TD, Deutsch R, McCutchan JA, Moore DJ, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I. San Diego HIV Neurobehavioral Research Center (HNRC) Group (2003). Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol, 60(10), 1406-12.

Mindt MR, Cherner M, Marcotte TD, Moore DJ, Bentley H, Esquivel MM, Lopez Y, Grant I, Heaton RK. (2003). The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol, 25(1), 122-32.

Polich J, Basho S. (2003). P3a and P3b auditory ERPs in HIV patients receiving anti-viral medication. Clin Electroencephalogr, 33(3), 97-101.

Redwine LS, Mills PJ, Sada M, Rakei, L, Patterson T, Dimsdale J, Grant I. (2003). Immune cell chemotaxis in response to a speech task in Alzheimer’s caregivers and non-caregiving controls. Psychosom Med, 65 (1), A18. (Abst.)

Ross MW, Mattison AM, Franklin DR. (2003). Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Subst Use Misuse, 38(8), 1173-83.

Samland H, Huitron-Resendiz S, Masliah E, Criado J, Henriksen SJ, Campbell IL. (2003). Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res, 73(2), 176-87.

Schweinsburg BC, Gonzalez R, Taylor MJ, Alhassoon OM, Cherner M, Brown GG, Grant I, and the HNRC Group. (2003). Age-related cerebral changes in abstinent methampetamine users. J Int Neuropsychol Soc, 9, 200. (Abst.)

Schweinsburg BC, Alhassoon OM, Taylor MJ, Gonzalez R, Videen JS, Brown GG, Patterson TL, Grant I. (2003). Effects of alcoholism and gender on brain metabolism. Am J Psychiatry, 160(6), 1180-3.

Semple SJ, Patterson TL, Grant I. (2003). HIV+ methamphetamine users: social and behavioral outcomes of binge use. Ann Behav Med, 25 (Suppl), S090. (Abst.)

Semple SJ, Patterson TL, Grant I. (2003). Binge use of methamphetamine among HIV-positive men who have sex with men: pilot data and HIV prevention implications. AIDS Educ Prev, 15(2), 133-47.

Taylor MJ, Letendre SL, Schweinsburg BC, Alhassoon OM, Grant I, and the HNRC Group. (2003). Reduced N-acetylaspartate related to Hepatitis C virus infection in abstinent methamphetamine users. J Int Neuropsychol Soc, 9, 246. (Abst.)

von Känel R, Dimsdale JE, Adler KA, Patterson TL, Grant I. (2003). Independent association between depressed mood severity and stress procoagulant activity and recovery in the elderly. Psychosom Med, 65 (1), A65. (Abst.)

von Känel R, Dimsdale JE, Adler KA, Patterson TL, Grant I. (2003). Fibrin turnover (plasma D-dimer) is higher in Alzheimer caregivers than in non-caregiving controls. Psychosom Med, 65 (1), A23. (Abst.)

Woods SP, Conover E, Rippeth JD, Carey CL, Gonzalez R, Marcotte TD, Heaton RK, Grant I. HIV Neurobehavioral Research Center (HNRC) Group (2003). Qualitative aspects of verbal fluency in HIV-associated dementia: a deficit in rule-guided lexical-semantic search processes?. Neuropsychologia, 42(6), 801-9.

Abramson I, Wolfson T, and the HNRC Group. (2002). A likelihood approximation and shrinkage for unbalanced repeated measures. Sankhya Series B, 64(3), 301-321.

Adler KA, Patterson TL, Mills PJ, Ziegler MG, Dimsdale JE, and Grant I. (2002). Sympathoadrenalmedullary dysregulation in elderly Alzheimer caregivers with high subjective burden and low resources. Ann Behav Med, 24 (Suppl), S79. (Abst.)

Blanchard JN, Powell HC, Freeman WR, Letendre S, Blanchard D, Shimizu C, Burns JC. (2002). Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome. Clin Infect Dis, 36(1), 105-11.

Carey C, Heaton RK, Marcotte T, Moore DJ, Rippeth J, Gonzalez R, Cherner M, Grant I, and the HNRC Group (2002). Brief neuropsychological assessment for the detection of HIV-related cognitive impairment. J Int Neuropsychol Soc, 8 (2), 251. (Abst.)

Carey C, Heaton RK, Rippeth J, Gonzalez R, Moore DJ, Marcotte T, Rivera Mindt M, Cherner M, Wolfson T, Grant I, and the HNRC Group. (2002). Impact of comorbid disorders on the neuropsychological performance of a methamphetamine dependent sample. J Int Neuropsychol Soc, 8 (2), 287. (Abst.)

Cherner M, Moore DJ, Masliah E, Ellis R, Heaton RK, Grant I, and the HNRC Group (2002). Relationship between neuropsychological impairment and post-mortem findings of HIV-associated brain disease. J Int Neuropsychol Soc, 8 (2), 314. (Abst.)

Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK. (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology, 59(10), 1563-7.

Cherner M, Heaton RK, Gonzalez R, Rippeth J, Carey C, Grant I, and the HNRC Group (2002). Exposure to methamphetamine and neuropsychological functioning. J Int Neuropsychol Soc, 8 (2), 250-251. (Abst.)

Childers M, Ellis R, Deutsch R, Wolfson T, Grant I, and the HNRC Group. (2002). The utility and limitations of the HIV Dementia Scale. J Int Neuropsychol Soc, 8 (2), 160. (Abst.)

Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM. Neurologic AIDS Research Consortium (2002). A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology, 59(10), 1568-73.

Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I. (2002). Progression to neuropsychological impairment in Human Immunodeficiency Virus infection predicted by elevated cerebrospinal fluid levels of Human Immunodeficiency Virus RNA. Arch Neurol, 59(6), 923-928.

Everall IP, Bell C, Mallory M, Langford D, Adame A, Rockestein E, Masliah E. (2002). Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol Cell Neurosci, 21(3), 493-501.

Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D`Emilia DM, Friedlander RM, Yuan J, Masliah E, Lipton SA. (2002). Caspase cascades in Human Immunodeficiency Virus-associated neurodegeneration. J Neurosci, 22(10), 4015-24.

Gonzalez R, Carey C, Grant I. (2002). Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic review. Journal of Clinical Pharmacology, 42(11), 48S-57S.

Gonzalez R., (2002). Effects of cannabis use on the cognitive performance of methamphetamine dependent individuals. J Int Neuropsychol Soc, 8 (2), 287-288. (Abst.)

Grant I., (2002). The neurocognitive complications of HIV infection. In Ramachandran, V.S. (Ed.) Encyclopedia of the Human Brain (pp. 475-489). San Diego, CA: Academic Press.

Grant I., (2002). Neuropsychology of HIV: from phenomenology to mechanisms and outcomes. J Int Neuropsychol Soc, 8 (2), 313. (Abst.)

Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, Everson A, Digicaylioglu M, Masliah E. (2002). Fibroblast Growth Factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway:implications for neuroprotection. J Biol Chem, 277(36), 32985-91.

Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, Everson A, Digicaylioglu M, Masliah E. (2002). Fibroblast Growth Factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway: implications for neuroprotection. J Biol Chem, 277(36), 32985-91.

Heaton RK, Rivera Mindt M, Marcotte T, Moore DJ, Weinburg K, Grant I, and the HNRC Group. (2002). The functional impact of HIV-associated neuropsychological impairment: a longitudinal study. J Int Neuropsychol Soc, 8 (2), 314-315. (Abst.)

Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. (2002). Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol, 54(Suppl 1), S44-52.

Langford D, Sanders VJ, Mallory M, Kaul M, Masliah E. (2002). Expression of stromal cell-derived factor 1 alpha protein in HIV encephalitis. J Neuroimmunol, 127(1-2), 115-26.

Langford D, Masliah E. (2002). Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases. J Neurovirol, 8(6), 625-38.

Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E, and the HNRC Group. (2002). Severe demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS, 16(7), 1019-1029.

Mattison AM, Ross MW, Wolfson T, Franklin D. San Diego HIV Neurobehavioral Research Center Group (2002). Circuit party attendance, club drug use, and unsafe sex in gay men. J Subst Abuse, 13(1-2), 119-26.

Miles LE, Patterson TL, Grant I, Dimsdale JE, Mills PJ. (2002). Psychological and physiological health and social desirability in African American and Caucasian Alzheimer’s caregivers. Ann Behav Med, 24(Suppl), S114. (Abst.)

Moore DJ, Cherner M, Masliah E, Gonzalez R, Carey C, Rippeth J, Marcotte T, Heaton RK, Grant I, and the HNRC Group. (2002). Neuropsychological ability and regional neuropathology in HIV. J Int Neuropsychol Soc, 8 (2), 187-188. (Abst.)

Rippeth J, Heaton RK, Carey C, Marcotte T, Moore DJ, Gonzalez R, Grant I. (2002). Effects of HIV infection and methamphetamine on specific cognitive domains. J Int Neuropsychol Soc, 8 (2), 188. (Abst.)

Rivera Mindt M, Ellis R, Moore DJ, Heaton RK, Deutsch R, Grant I, and the HNRC Group. (2002). The roles of HIV RNA viral load and highly active antiretroviral treatment (HAART) in incident HIV-associated neuropsychological impairment. J Int Neuropsychol Soc, 8 (2), 314. (Abst.)

Rivera Mindt M, Heaton RK, Marcotte T, Moore DJ, Weinberg K, Grant I, and the HNRC Group. (2002). Vocational ability, employment, and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc, 8 (2), 188. (Abst.)

Semple SJ, Patterson TL, Grant I. (2002). Motivations associated with methamphetamine use among HIV+ men who have sex with men. Journal of Substance Abuse Treatment, 22 (3), 149-56.

Semple SJ, Patterson TL, Grant I. (2002). Gender differences in the sexual risk practices of HIV+ heterosexual men and women. AIDS Behav, 6(1), 45-54.

Taylor MJ, Schweinsburg BC, Alhassoon OM, Brown GG, Heaton RK, Grant I, and the HNRC Group. (2002). Concordance of MR spectroscopic and neuropsychological deficits in HIV and methamphetamine dependence. J Int Neuropsychol Soc, 8 (2), 314. (Abst.)

Taylor MJ, Heaton RK. (2002). Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc, 7(7), 867-74.

Treffke H, Tiggemann M, Ross MW. (2002). The relationship between attitude, assertiveness and condom use. Psychol Health, 6(1-2), 45-52.

Adler KA, Mills PJ, Dimsdale JE, Ziegler MG, Patterson TL, Sloan RP, Grant I. (2001). Temporal stability of stress-induced changes in cell adhesion molecule expression in older adults. Psychosom Med, 63, A159. (Abst.)

Alhassoon OM, Dupont RM, Schweinsburg BC, Taylor MJ, Patterson TL, Grant I. (2001). Regional cerebral blood flow in cocaine- versus methamphetamine-dependent patients with a history of alcoholism. International Journal of Neuropsychopharmacology, 4(2), 105-112.

Atkinson JH, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. (2001). Prevalence of psychiatric disorders among men infected with Human Immunodeficiency Virus: a controlled study. Arch Gen Psychiatry, 45(9), 859-64.

Cherner M, Ellis R, Marcotte T, Heaton R, Grant I, and the HNRC Group. (2001). Learning impairments on the California Verbal Learning Test are related to methamphetamine abuse and HIV status. J Int Neuropsychol Soc, 6, 232. (Abst.)

Cherner M, Masliah E, Heaton R, Ellis R, Grant I, and the HNRC Group. (2001). Value of neurocognitive status in predicting HIV-related brain disease. J Int Neuropsychol Soc, 7, 150. (Abst.)

Deutsch R, Ellis RJ, McCutchan JA, Marcotte TD, Letendre S, Grant I, and the HNRC Group. (2001). AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS, 15(14), 1898-1899.

Everall IP, Trillo-Pazos G, Bell C, Mallory M, Sanders V, Masliah E. (2001). Amelioration of neurotoxic effects of HIV envelope protein Gp120 by fibroblast growth factor: a strategy for neuroprotection. J Neuropathol Exp Neurol, 60(3), 293-301.

Heaton R, Moore D, Marcotte T, Reicks C, Weinberg K, Grant I, and the HNRC Group. (2001). Everyday functioning in individuals with HIV-associated neuropsychological impairment. J Int Neuropsychol Soc, 7, 229. (Abst.)

Heaton RK, Temkin N, Dikmen S, Avitable N, Taylor MJ, Marcotte TD, Grant I. (2001). Detecting change: a comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol, 16(1), 75-91.

Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, Archibald S, Jernigan TL, and the HNRC Group. (2001). Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain, 124(Pt5), 1033-1042.

Jernigan TL, Archibald SL, Fennema-Notestine C, Gamst AC, Stout JC, Bonner J, Hesselink JR. (2001). Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging, 22(4), 581-94.

Langford D, Masliah E. (2001). Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol, 11(3), 306-12.

Lanier ER, Sturge G, McClernon D, Brown S, Halman M, Sacktor N, McArthur J, Atkinson JH, Clifford D, Price RW, Simpson D, Torres G, Catalan J, Marder K, Power C, Hall C, Romero C, Brew B. (2001). HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. AIDS, 15(6), 747-51.

Marcotte T, Heaton R, Gonzalez R, Reicks C, Grant I, and the HNRC Group. (2001). Assessing driving abilities in HIV-infected individuals with mild NP impairment. J Int Neuropsychol Soc, 7, 230. (Abst.)

Marcotte TD, Grant I, Atkinson JH, Heaton RK. (2001). Neurobehavioral complications of HIV infection. In RE Tarter, M Butters, SR Beers (Eds.) Medical Neuropsychology, 2nd Edition (pp. 285-331). New York: Kluwer Academic/Plenum Publishers.

Moore D, Gonzalez R, Heaton R, Rippeth J, Cherner M, Grant I, and the HNRC Group. (2001). Cognitive complaints neuropsychological ability, and depressive symptoms in HIV. J Int Neuropsychol Soc, 7, 149. (Abst.)

Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ. (2001). The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathology and Applied Neurobiology, 27, 326-335.

Rippeth J, Moore D, Gonzalez R, Dawson L, Marcotte T, Heaton R, Grant I, and the HNRC Group. (2001). Neuropsychological effects of HIV infection and methamphetamine dependence. J Int Neuropsychol Soc, 7, 149. (Abst.)

Rivera Mindt M, Cherner M, Esquivel M, Bentley H, Heaton RK, Marcotte TD, Grant I, and the HNRC Group. (2001). Functional and cognitive impact of HIV in Spanish-speakers: a pilot study. Archives of Clinical Neuropsychology, 16, 734. (Abst.)

Schweinsburg BC, Taylor MJ, Alhassoon OM, Videen JS, Brown GG, Patterson TL, Berger F, Grant I. (2001). Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res, 25(6), 924-934.

Schweinsburg BC, Gonzalez R, Taylor MJ, Alhassoon OM, Ellis RJ, McCutchan JA, Brown GG, Videen JS, Patterson TL, Grant I. (2001). 1H MR spectroscopy reveals NRTI associated mitochondrial impairment in HIV-infected individuals. Society of Neuroscience Abstracts, 27(2), 527.14. (Abst.)

Semple SJ, Patterson TL, Grant I. (2001). Sexual risk practices of HIV+ gay men and their anonymous partners. Ann Behav Med, 23, 14. (Abst.)

Taylor MJ, Schweinsburg BC, Alhassoon OM, Brown GG, Videen JS, Patterson TL, Grant I. (2001). MR spectroscopy provides evidence of early aging in the brains of alcoholics. Alcohol Clin Exp Res, 25(6), 79A. (Abst.)

von Känel R, Dimsdale JE, Patterson TL, Grant I. (2001). Acute mental stress triggers a hypercoagulable state in cardiovascular disease. Psychosom Med, 63, A172. (Abst.)

von Känel R, Dimsdale JE, Patterson TL, Grant I. (2001). Negative life stress increases coagulation activity in Alzheimer caregivers. Psychosom Med, 63, A96. (Abst.)

Wallace MR, Nelson JA, McCutchan JA, Wolfson T, Grant I, and the HNRC Group. (2001). Symptomatic HIV seroconverting illness is associated with more rapid neurologic impairment. Sexually Transmitted Infections, 77, 199-201.

Wallace MR, Heaton RK, McCutchan JA, Malone JL, Velin R, Nelson J, Miller LK, Weiss PJ. Oldfield EC, Grant I. (2001). Neurocognitive impairment in Human Immunodeficiency Virus infection is correlated with sexually transmitted disease history. Sex Transm Dis, 24(7), 398-401.

Wallace MR, Persing DH, McCutchan JA, Magara J, Nelson JA, Heaton RK, Tasker SA, Grant I. (2001). Bartonella henselae serostatus is not correlated with neurocognitive decline in HIV infection. Scandinavian Journal of Infectious Diseases, 33(8), 593-595.

Weinrich JD, Atkinson JH, McCutchan JA, Grant I. The HIV Neurobehavioral Research Center. (2001). Is gender dysphoria dysphoric? Elevated depression and anxiety in gender dysphoric and nondysphoric homosexual and bisexual men in an HIV sample.. Arch Sex Behav, 24(1), 55-72.

Wiley CA, Achim C, Hammond R, Love S, Masliah E, Radhakrishnan L, Sanders V, Wang G. (2001). Damage and repair of DNA in HIV encephalitis. J Neuropathol Exp Neurol, 59(11), 955-65.

Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. (2001). A health status questionnaire using 30 items from the Medical Outcomes Study Preliminary validation in persons with early HIV infection. Med Care, 29(8), 786-98.

Adams KM, Heaton RK. (2000). Statement concerning the NIMH neuropsychological battery. J Clin Exp Neuropsychol, 12(6), 960-2.

Butters N, Grant I, Haxby J, Judd LL, Martin A, McClelland J, Pequegnat W, Schacter D, Stover E. (2000). Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. J Clin Exp Neuropsychol, 12(6), 963-78.

Ellis RJ, Letendre SL., Deutsch R, Hsia K., Spector SA, McCutchan JA, and the HNRC Group. (2000). Demonstration of a different "set point" for HIV RNA in CSF, as compared to plasma. J Neurovirol, , . (Abst.)

Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA. (2000). Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology, 54(4), 927-36.

Gonzalez R, Heaton RK, Moore D, Marcotte T, Cherner M, Grant I, and the HNRC Group. (2000). Neurocognitive impairment classifications using the CalCAP and a traditional neuropsychological battery in HIV+ men. J Int Neuropsychol Soc, 6, 232. (Abst.)

Gonzalez RG, Cheng LL, Westmoreland SV, Sakaie KE, Becerra LR, Lee PL, Masliah E, Lackner AA. (2000). Early brain injury in the SIV-Macaque Model of AIDS. AIDS, 14(18), 2841-9.

Heaton RK, Marcotte TD. (2000). Clinical and neuropsychological tests and assesment techniques. In F Boller, J Grafman and G Rizzolatti (Eds.) Handbook of Neuropsychology (pp. 27-52). Amsterdam: Elsevier Science B.V..

Letendre SL, Capparelli EV, Ellis RJ, McCutchan JA, and the HNRC Group. (2000). Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. Antimicrob Agents Chemother, 44(8), 2173-5.

Letendre SL, Lanier ER, McCutchan JA. (2000). Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with Human Imunodeficiency Virus Type 1. J Infect Dis, 180(2), 310-9.

Marcotte T, Heaton RK, Reicks C, Gonzalez R, Grant I, and the HNRC Group. (2000). HIV-related neuropsychological impairment and automobile driving. J Int Neuropsychol Soc, 6, 233. (Abst.)

Masliah E, de Teresa RM, Mallory ME, Hansen LA. (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS, 14(1), 69-74.

Masliah E, Alford M, Mallory M, Rockenstein E, Moechars D, van Leuven F. (2000). Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp Neurol, 163(2), 381-7.

Moore D, Dawson L, Gonzalez R, Cherner M, Marcotte T, Grant I, Heaton R, and the HNRC Group. (2000). Neuropsychological test performance in HIV+ individuals with and without pain complaints. J Int Neuropsychol Soc, 6, 233. (Abst.)

Norman MA, Evans JD, Miller WS, Heaton RK. (2000). Demographically corrected norms for the California Verbal Learning Test. J Clin Exp Neuropsychol, 22(1), 80-94.

Patterson TL, Semple SJ, Grant I. (2000). Partner type variations in sexual risk behavior among HIV+ gay and bisexual men. Ann Behav Med, 22 (Suppl.), S073. (Abst.)

Peavy G, Jacobs D, Salmon DP, Butters N, Delis DC, Taylor M, Massman P, Stout JC, Heindel WC, Kirson D. The HNRC Group. (2000). Verbal memory performance of patients with Human Immunodeficiency Virus infection: evidence of subcortical dysfunction. J Clin Exp Neuropsychol, 16(4), 508-23.

Sanders VJ, Everall IP, Johnson RW, Masliah E, and the HNRC Group. (2000). Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells. J Neurosci Res, 59(5), 671-9.

Semple SJ, Patterson TL, Grant I. (2000). Partner type and sexual risk behavior among HIV+ gay and bisexual men: social cognitive correlates. AIDS Educ Prev, 12, 340-56.

Semple SJ, Patterson TL, Grant I. (2000). The sexual negotiation behavior of HIV-positive gay and bisexual men. J Consult Clin Psychol, 68, 934-7.

Semple SJ, Patterson TL, Grant I. (2000). Psychosocial predictors of unprotected anal intercourse in a sample of HIV positive gay men who volunteer for a sexual risk reduction intervention. AIDS Educ Prev, 12, 416-30.

Semple SJ, Patterson TL, Grant I. (2000). Sexual risk practices of HIV+ heterosexual men and women. Ann Behav Med, 22 (Suppl.), S073. (Abst.)

Summers J, Robinson R, Capps L, Zisook S, Atkinson JH, McCutchan E, McCutchan JA, Deutsch R, Patterson T, Grant I. (2000). The influence of HIV-related support groups on survival in women who lived with HIV. Psychosomatics, 41(3), 262-268.

Taylor MJ, Alhassoon OM, Schweinsburg BC, Videen JS, Grant I, and the HNRC Group. (2000). MR spectroscopy in HIV and stimulant dependence. J Int Neuropsychol Soc, 6(1), 83-85.

Taylor MJ, Alhassoon OM, Schweinsburg BC, Videen JS, Patterson T, Grant I, and the HNRC Group. (2000). Reduced N-acetylaspartate related to neuropsychological deficits in methamphetamine users: a magnetic resonance spectroscopy study. J Int Neuropsychol Soc, 6, 236. (Abst.)

Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD. (2000). CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. AIDS, 14(2), 173-80.

White DA, Taylor MJ, Butters N, Mack C, Salmon DP, Peavy G, Ryan L, Heaton RK, Atkinson JH, Chandler JL, Grant I, and the HNRC Group. (2000). Memory for verbal information in individuals with HIV-associated dementia complex. J Clin Exp Neuropsychol, 19(3), 357-66.

Abramson I, Wolfson T, Marcotte TD, Grant I, and the HNRC Group. (1999). Extending the p-plot: heuristics for multiple testing. J Int Neuropsychol Soc, 5(6), 510-517.

Cherner, M, Diehr M, Marcotte T, Heaton R, Miller W, Grant I, and the HNRC Group. (1999). Validation of the PASAT 50-item and 100-itdem short forms in an HIV infected sample. Archives of Clinical Neuropsychology, 14, 703. (Abst.)

Dikmen SS, Heaton RK, Grant I, Temkin NR. (1999). Test-retest reliability and practice effects of Expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc, 5(4), 346-356.

Ellis RJ, Seubert P, Motter R, Galasko D, Deutsch R, Heaton RK, Heyes MP, McCutchan JA, Atkinson JH, Grant I, and the HNRC Group. (1999). Cerebrospinal fluid TAU protein in not elevated in HIV-associated neurologic disease in humans. Neuroscience Letters, 254(1), 4-Jan.

Espey MG, Ellis RJ, Heaton RK, Basile AS. (1999). Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex. Neurology, 53(5), 1144-5.

Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E. HNRC Group. HIV Neurobehavioral Research Center. (1999). Cortical synaptic density is reduced in mild to moderate Human Immunodeficiency Virus neurocognitive disorder. Brain Pathol, 9(2), 209-17.

Gladsjo JA, Heaton RK, Palmer BW, Taylor MJ, Jeste DV. (1999). Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. J Int Neuropsychol Soc, 5(3), 247-54.

Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK. (1999). Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment, 6(2), 147-78.

Grant I, Heaton RK, Dawson LK, Marcotte TD. (1999). Abuse of methamphetamine and cocaine may enhance HIV associated neurotoxicity. The International Journal of Neuropsychopharmacology, 2 (suppl. 1), S172. (Abst.)

Grant I, Marcotte TD, Heaton RK, and the HNRC Group. (1999). Neurocognitive complications of HIV disease. Psychological Science, 10(3), 191-195.

Grant, I., Atkinson, J.H. (1999). Neuropsychiatric aspects of HIV infection and AIDS. In Sadock, B.J., and Sadock, V.A., (Eds.) Kaplan and Sadock's Comprehensive Textbook of Psychiatry VII (pp. 308-335). Baltimore: Williams and Wilkins.

Heaton RK, Avitable N, Grant I, Matthews CG. (1999). Further crossvalidation of regression-based neuropsychological norms with an update for the Boston Naming Test. J Clin Exp Neuropsychol, 21, 572-582.

Kaplan RM, Patterson TL, Kerner D, Grant I. (1999). Apoyo social y salud en los transtornos por inmunodeficiencia adquirida (this is the Spanish version of Social support: cause or consequence of poor health outcomes in men with HIV infection?). In Buendia, J., (Ed.) Psicologia Clinica (pp. 187-203). Madrid: Ediciones Piramide.

Lyman WD, Hao HN, Grant I. (1999). Amantidine inhibits HIV infection of astrocytes. The International Journal of Neuropyshcopharmacology, 2 (suppl. 1), S173. (Abst.)

Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, Ellis RJ, Grant I, and the HNRC Group. (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. J Int Neuropsychol Soc, 5(7), 579-592.

Plummer DJ, Marcotte TD, Sample PA, Wolfson T, Heaton RK, Grant I, Freeman WR. HNRC Group. HIV Neurobehavioral Research Center. (1999). Neuropsychological impairment-associated visual field deficits in HIV infection. Invest Ophthalmol Vis Sci, 40(2), 435-42.

Reicks CJ, Moore DJ, Dawson LK, Marcotte TD, Heaton RK, Grant I, and the HNRC Group. (1999). Neuropsychological performance predicts everyday functioning in HIV+ individuals. J Int Neuropsychol Soc, 5, 154. (Abst.)

Sample PA, Plummer DJ, Mueller AJ, Matsubara KI, Sadun A, Grant I, Freeman WR. (1999). Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol, 117(6), 755-760.

Semple SJ, Patterson TL, Shaw WS, Pedlow CT, Grant I. (1999). Disclosure of HIV seropositivity to sexual partners: an application of Social Cognitive Theory. Behavior Therapy, 30, 223-37.

Symonds LL, Archibald SL, Grant I, Zisook S, Jernigan TL. (1999). Does an increase in sulcal or ventricular fluid predict where brain tissue is lost?. J Neuroimaging, 9(4), 201-209.

Taylor MJ, Schweinsburg BC, Alhassoon OM, Videen JS, Grant I, and the HNRC Group. (1999). Additive effects of HIV and stimulant dependence as measured by proton magnetic resonance spectroscopy. J Int Neuropsychol Soc, 5, 155. (Abst.)

Temkin NR, Heaton RK, Grant I, Dikmen SS. (1999). Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc, 5(4), 357-369.

Wiley CA, Achim CL, Christopherson C, Kidane Y, Kwok S, Masliah E, Mellors J, Radhakrishnan L, Wang G, Soontornniyomkij V. (1999). HIV mediates a productive infection of the brain. AIDS, 13(15), 2055-9.

Buttini M, Westland CE, Masliah E, Yafeh AM, Wyss-Coray T, Mucke L. (1998). Novel role of human CD4 molecule identified in neurodegeneration. Nat Med, 4(4), 441-6.

Cherner M, Patterson T, Semple S, Atkinson JH, Grant I, and the HNRC Group. (1998). Ethnicity does not predict psychological adaptation in HIV. Ann Behav Med, 20 (suppl.), S162. (Abst.)

Diehr MC, Heaton RK, Miller W, Grant I. (1998). The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity. Assessment, 5(4), 375-87.

Diehr MC, Marcotte TD, Heyes MP, Nelson JA, Ellis RJ, McCutchan JA, Heaton RK, Grant I, and the HNRC Group. (1998). CSF quinolinic acid is associated with reduced speed of processing in HIV-1 infection. J Neurovirol, 4, 347. (Abst.)

Diehr MC, Marcott